November 20th, 2012
PFO Occluder Devices Don’t Get No RESPECT
L. David Hillis, MD
David Hillis invokes Rodney Dangerfield in considering the findings of a recent trial of a PFO closure device.
September 24th, 2010
ACC Will Co-Sponsor TCT Symposium in 2011
Larry Husten, PHD
The American College of Cardiology (ACC) will be a co-sponsor of the TCT Symposium in 2011, the ACC and the Cardiovascular Research Foundation (CRF) announced on Thursday. The arrangement will deepen the existing relationship between the two organizations, which already collaborate on the Innovations in Interventions (i2) Summit at ACC’s Annual Scientific Sessions. In a blog post, […]
September 20th, 2010
What Does Gregg Stone Most Want to See at TCT This Year?
Gregg W Stone, MD
CardioExchange asked Gregg Stone, Director of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 meeting, what he thinks will be the three most important trials or topics presented at this year’s conference. The most important and impactful trial is undoubtedly the PARTNER trial, which is a large randomized trial of transcatheter aortic valve implantation compared to medical therapy […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?